fluoxetine has been researched along with Psychomotor Agitation in 19 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Psychomotor Agitation: A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment-emergent adverse effects were assessed at each study visit." | 1.32 | Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. ( Fava, M; Lamon-Fava, S; Lin, KM; Mischoulon, D; Perlis, RH; Rosenbaum, JF; Smoller, JW; Wan, YJ, 2003) |
| "All three patients developed severe akathisia during retreatment with fluoxetine and stated that the development of the akathisia made them feel suicidal and that it had precipitated their prior suicide attempts." | 1.28 | Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. ( Locke, CA; Rothschild, AJ, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 11 (57.89) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pande, CK | 1 |
| O'Halloran, A | 1 |
| Stewart, RW | 1 |
| Nguyen, A | 1 |
| Canares, T | 1 |
| Abouchedid, R | 1 |
| Ho, JH | 1 |
| Hudson, S | 1 |
| Dines, A | 1 |
| Archer, JR | 1 |
| Wood, DM | 1 |
| Dargan, PI | 1 |
| Vitiello, B | 1 |
| Silva, SG | 1 |
| Rohde, P | 1 |
| Kratochvil, CJ | 1 |
| Kennard, BD | 1 |
| Reinecke, MA | 1 |
| Mayes, TL | 1 |
| Posner, K | 1 |
| May, DE | 1 |
| March, JS | 1 |
| Ziv, L | 1 |
| Muto, A | 1 |
| Schoonheim, PJ | 1 |
| Meijsing, SH | 1 |
| Strasser, D | 1 |
| Ingraham, HA | 1 |
| Schaaf, MJ | 1 |
| Yamamoto, KR | 1 |
| Baier, H | 1 |
| Perlis, RH | 1 |
| Mischoulon, D | 1 |
| Smoller, JW | 1 |
| Wan, YJ | 1 |
| Lamon-Fava, S | 1 |
| Lin, KM | 1 |
| Rosenbaum, JF | 1 |
| Fava, M | 1 |
| Preskorn, SH | 1 |
| Tollefson, GD | 1 |
| Greist, JH | 1 |
| Jefferson, JW | 1 |
| Heiligenstein, JH | 1 |
| Sayler, ME | 2 |
| Tollefson, SL | 1 |
| Koback, K | 1 |
| Stoll, AL | 1 |
| Mayer, PV | 1 |
| Kolbrener, M | 1 |
| Goldstein, E | 1 |
| Suplit, B | 1 |
| Lucier, J | 1 |
| Cohen, BM | 1 |
| Tohen, M | 1 |
| Conway, A | 1 |
| Auchus, AP | 1 |
| Bissey-Black, C | 1 |
| Dantchev, N | 1 |
| Widlöcher, DJ | 1 |
| Wirshing, WC | 1 |
| Van Putten, T | 1 |
| Rosenberg, J | 1 |
| Marder, S | 1 |
| Ames, D | 1 |
| Hicks-Gray, T | 1 |
| Pearlman, T | 1 |
| Rothschild, AJ | 1 |
| Locke, CA | 1 |
| Fleischhacker, WW | 1 |
| Beasley, CM | 1 |
| Bosomworth, JC | 1 |
| Wernicke, JF | 1 |
| Friedman, EH | 1 |
| Lipinski, JF | 1 |
| Mallya, G | 1 |
| Zimmerman, P | 1 |
| Pope, HG | 1 |
| Sobin, P | 1 |
| Schneider, L | 1 |
| McDermott, H | 1 |
4 trials available for fluoxetine and Psychomotor Agitation
| Article | Year |
|---|---|
Suicidal events in the Treatment for Adolescents With Depression Study (TADS).
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Depressive Disorder, Major; Diagnostic and Statisti | 2009 |
Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Contraindications; Depressive Disorder; Double-Bli | 1994 |
Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Double-Blin | 1997 |
High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression.
Topics: Adolescent; Adult; Aged; Depression; Drug Administration Schedule; Female; Fluoxetine; Humans; Hypno | 1991 |
15 other studies available for fluoxetine and Psychomotor Agitation
| Article | Year |
|---|---|
Case 2: Agitation and Abnormal Movements in a 14-year-old Boy.
Topics: Adolescent; Dopamine Uptake Inhibitors; Dyskinesias; Fluoxetine; Humans; Lisdexamfetamine Dimesylate | 2019 |
Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.
Topics: Adamantane; Administration, Intravenous; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Citalop | 2016 |
An affective disorder in zebrafish with mutation of the glucocorticoid receptor.
Topics: Analysis of Variance; Animals; Animals, Genetically Modified; Anti-Anxiety Agents; Arginine; Brain; | 2013 |
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.
Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Carrier Proteins; Depressive Disorder, Maj | 2003 |
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; | 2008 |
Antidepressant-associated mania: a controlled comparison with spontaneous mania.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Dis | 1994 |
Difficulties in managing a case of stupor.
Topics: Adult; Akinetic Mutism; Combined Modality Therapy; Consciousness Disorders; Droperidol; Female; Fluo | 1993 |
The measurement of retardation in depression.
Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle A | 1998 |
Fluoxetine, akathisia, and suicidality: is there a causal connection?
Topics: Adult; Akathisia, Drug-Induced; Depressive Disorder; Female; Fluoxetine; Humans; Middle Aged; Psycho | 1992 |
Fluoxetine and suicidality.
Topics: Akathisia, Drug-Induced; Anxiety Disorders; Basal Ganglia Diseases; Depressive Disorder; Dose-Respon | 1992 |
Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia.
Topics: Adult; Akathisia, Drug-Induced; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; | 1991 |
Propanolol for fluoxetine-induced akathisia.
Topics: Akathisia, Drug-Induced; Depressive Disorder; Female; Fluoxetine; Humans; Middle Aged; Neurologic Ex | 1991 |
Fluoxetine and stuttering.
Topics: Adult; Akathisia, Drug-Induced; Depressive Disorder; Diagnosis, Differential; Female; Fluoxetine; Hu | 1990 |
Fluoxetine-induced akathisia: clinical and theoretical implications.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Depressive Disorder; Dopamine; Dyskinesia, Drug-Induced; | 1989 |
Fluoxetine in the treatment of agitated dementia.
Topics: Aggression; Dementia; Fluoxetine; Humans; Male; Middle Aged; Psychomotor Agitation | 1989 |